5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The pathogenetic mechanisms by which HLA-DRB1 alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk HLA-DRB1 alleles are known to share a common motif, the ‘shared susceptibility epitope (SE)’. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism.

          Methods

          HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg 59–71, vimentin-64Cit 59–71 and fibrinogen β−74Cit 69–81 were solved using X-ray crystallography. Vimentin-64Cit 59–71-specific and vimentin 59–71-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing.

          Results

          ACPA + RA in INA was independently associated with HLA-DRB1*14:02. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin 59–71 were observed in patients with HLA-DRB1*14:02 + RA and at-risk ACPA first-degree relatives. HLA-DRB1*14:02-vimentin 59–71-specific and HLA-DRB1*14:02-vimentin-64Cit 59–71-specific CD4+ memory T cells were phenotypically distinct populations.

          Conclusion

          HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA.

          Related collections

          Author and article information

          Journal
          0372355
          640
          Ann Rheum Dis
          Ann. Rheum. Dis.
          Annals of the rheumatic diseases
          0003-4967
          1468-2060
          28 August 2019
          11 August 2017
          November 2017
          04 September 2019
          : 76
          : 11
          : 1915-1923
          Affiliations
          [1 ]Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute Monash University, Clayton, Australia
          [2 ]The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia
          [3 ]Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
          [4 ]Department of Medicine/Immunology and Rheumatology, Stanford University, VA Palo Alto Health Care System, Palo Alto, California
          [5 ]Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
          [6 ]Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
          [7 ]Faculty of Agricultural Technology, Technological Educational Institute of Ionian Islands, Argostoli Kefalonia, Greece
          [8 ]Laboratory of Biochemistry and Biophysics, Faculty of Agricultural Technology, Epirus Institute of Technology, Arta, Greece
          [9 ]Arthritis Centre, University of Manitoba, Winnipeg, Manitoba, Canada
          [10 ]Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA
          [11 ]Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
          [12 ]Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA
          [13 ]Center for Data Sciences, Brigham and Women’s Hospital, Boston, Massachusetts, USA
          [14 ]Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, UK
          [15 ]Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK
          [16 ]Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia
          Author notes

          SWS and S-CL contributed equally.

          Contributors Concept and design of the study: RT, HE-G, JR, RET, SWS, S-CL. Data collection, data analysis and interpretation: SWS, S-CL, YTT, JvH, JS, AJD, EBC, AKM, GKP, DvdW, IS, CAH, DBR, EDF, CNB, XM, VA, TH, KK, HHR, SR. Manuscript preparation: SWS, S-CL, JvH, RT, JR, RET, HE-G. All authors revised and approved the manuscript to be published.

          Correspondence to: Professor Ranjeny Thomas, University of Queensland Diamantina Institute, Level 4, R Wing, Princess Alexandra Hospital, Ipswich Road, Woolloongabba 4102, Queensland, Australia; ranjeny.thomas@ 123456uq.edu.au
          Article
          PMC6724216 PMC6724216 6724216 nihpa1047772
          10.1136/annrheumdis-2017-211300
          6724216
          28801345
          0c91c764-ba67-4f70-abd1-d914ae2c0960
          History
          Categories
          Article

          Comments

          Comment on this article